Filter
1894
Text search:
SARS-CoV-2
Featured
275
4
Language
Document type
751
328
290
108
99
94
67
38
36
31
23
20
9
Countries / Regions
151
125
87
81
73
59
58
52
42
41
39
37
37
35
35
33
30
29
28
25
23
23
23
22
22
21
16
15
14
13
12
12
12
11
11
10
10
10
9
9
9
9
9
9
8
8
8
8
7
7
7
7
6
6
6
6
6
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
991
48
36
30
28
25
15
2
Toolboxes
1573
55
28
26
25
18
18
14
11
10
10
10
9
8
7
6
6
4
4
2
2
1
A recent study informed that ivermectin was successfully used in vitro for the treatment of SARS-CoV-2 in experimentally infected cells and two pre
...
ESTUDIO ENE-COVID19: Segunda Ronda del Estudio Nacional de Sero-Epidemiología de la Infección por SARS-CoV-2 en España; Informe preliminar 3 de
...
Non-pharmaceutical interventions (NPI) are public health measures that aim to prevent and/or control SARS-CoV-2 transmission in the community. As l
...
La promoción del lavado de manos es fundamental para minimizar la transmisión de SARS-COV-2 y para salvar vidas. Una de las maneras más frecuent
...
A Fiocruz tem produzido uma série de materiais informativos sobre a pandemia da doença pelo SARS-CoV-2 (Covid-19). A reprodução do material é
...
CONVIDECIA is based on a modified human adenovirus that expresses the spike S protein of SARS-CoV-2. It is administered as a single dose.
Globally, more than 3 million new cases and 10 000 deaths have been reported in the week of 26 December 2022 to 1 January 2023. This represents a reduction in weekly cases and deaths of 22% and 12%, respectively. In the last 28 days (5 December 2022 to 1 January 2023), over 14.5 million cases and ov
...
The ICMR type 1 diabetes guidelines come at a time when the SARS-CoV-2 pandemic
has disproportionately affected people with diabetes population, e
...
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-
...
Coronavirus disease 2019 (COVID-19) is an acute infectious respiratory disease caused by a newly discovered coronavirus (SARS-CoV-2).
Most people
...
Evidencias COVID-19 es un recurso que ofrece información relevante relacionada con la pandemia del coronavirus SARS-CoV-2 y la COVID-19.
Este r
...
10 May 2021
This scientific brief replaces the WHO Scientific Brief entitled “’Immunity passports’ in the context of COVID-19”, published 24 April 2020.
This update is focused on what is currently understood about SARS-
...
Esta é a primeira edição de orientações sobre estratégias de prevenção e controle de infecção (PCI) para utilizar quando houver suspeita de infecção por um novo coronavírus (2019-nCoV). Foi adaptado do guia da OMS de Prevenção e controle de infecções durante os cuidados de saúde pa
...
Esta é a primeira edição da orientação sobre estratégias de prevenção e controle de infecções (PCI) que devem ser aplicadas quando houver suspeita de COVID-19. Ela foi adaptada do documento da OMS sobre prevenção e controle de infecções durante prestação de cuidados de saúde para ca
...
Dieser Leitfaden zum Management von COVID-19 Ausbruechen richtet sich in erster Linie an die Fachöffentlichkeit im Gesundheitswesen, insbesondere den ÖGD auf allen Ebenen. Er verweist auf viele bereits existierende generische sowie für COVID-19 entwickelten Dokumente. Diese Empfehlungen sind alle
...
Nested case-control study of health workers exposed to confirmed COVID-19 patients.
Similar objectives to the cohort study but case-control studies may be cheaper and provide robust evidence to characterize and assess the risk factors for SARS-
...
Das Tragen von Mund-Nasen-Bedeckungen kann neben anderen Maßnahmen nach aktuellem Wissensstand helfen, die Verbreitung des Coronavirus SARS-CoV-2
...
Letzte Aktualisierung: 19.06.2020
Krebspatientinnen und Krebspatienten sind nach Aussage der Experten durch das neuartige Coronavirus (SARS-CoV-2
...
22 July 2022. This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-
...
Ausführliche Informationen zu klinischen Prüfungen und Risiken für bestimmte Gruppen sowie zu Wechselwirkungen und Nebenwirkungen von Impfstoffen und Arzneimitteln zu COVID-19 und SARS-CoV-
...
